Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

2.29
Delayed Data
As of 3:59pm ET
 -0.02 / -0.87%
Today’s Change
2.05
Today|||52-Week Range
4.80
-0.43%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close2.31
Today’s open2.28
Day’s range2.28 - 2.31
Volume28,950
Average volume (3 months)92,651
Market cap$25.6M
Dividend yield--
Data as of 3:59pm ET, 03/30/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)+6.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-30.64%
P/E ratioNM
Price/Sales1.59
Price/Book0.57

Competitors

 Today’s
change
Today’s
% change
AVIRAviragen Therapeutic...-0.01-1.00%
NVGNNovogen Ltd+0.05+3.68%
IMNPImmune Pharmaceutica...+0.00+0.66%
CERUCerulean Pharma Inc-0.07-7.68%
Data as of 3:59pm ET, 03/30/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$14.5M
Annual profit (last year)-$9.0M
Net profit margin-61.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Operations
Keith D. Hall
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs